Advertisement
Screener

PTC Therapeutics, Inc. (PTCT) EBITDA

PTC THERAPEUTICS, INC. EBITDA

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of the cash a company's operations generate before accounting charges for wearing out its assets. Here it is operating income plus the filed depreciation and amortization, not a figure the company adjusted itself. Higher EBITDA means more operating profit before those charges. It is not an official accounting (GAAP) measure and does not subtract capital spending, interest or tax, so it does not show what those obligations cost.

  • PTC THERAPEUTICS, INC. ebitda for the quarter ending 2026-06-30 was $164.85M, a change of $192.23M year-over-year.
  • PTC THERAPEUTICS, INC. ebitda for the quarter ending 2026-03-31 was $60.37M, a 93.82% decline year-over-year.
  • PTC THERAPEUTICS, INC. ebitda for the quarter ending 2025-12-31 was -$58.45M, a change of $97.18M year-over-year.
  • PTC THERAPEUTICS, INC. ebitda for the quarter ending 2025-09-30 was $14.13M, a change of $62.15M year-over-year.
  • PTC THERAPEUTICS, INC. ebitda for fiscal 2025 was $905.75M, a change of $1.13B from fiscal 2024.
  • PTC THERAPEUTICS, INC. ebitda for fiscal 2024 was -$226.91M, a change of -$24M from fiscal 2023.
  • PTC THERAPEUTICS, INC. ebitda for fiscal 2023 was -$202.91M, a change of $115.66M from fiscal 2022.
  • PTC THERAPEUTICS, INC. ebitda for fiscal 2022 was -$318.57M, a change of -$8.26M from fiscal 2021.
Available history
2011-12-31 to 2026-06-30
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported$164.85M$148.98M$15.87M(m)(m)$2.19M*$129.11M*(m)$99.15M$80.63M$14.05M
2026-03-31Reported$60.37M$44.96M$15.41M(m)22.15%$1.20M-$59.04M(m)$100.87M$86.18M$347.00K
2025-12-31Reported-$58.45M-$71.35M$12.9M(m)-35.49%(m)(m)(m)(m)(m)(m)
2025-09-30Reported$14.13M$3.02M$11.11M(m)(m)$3.52M*-$66.30M*(m)$100.16M$84.05M-$38.97M
2025-06-30Reported-$27.37M-$34.96M$7.58M(m)(m)$1.25M*-$58.33M*(m)$112.99M$85.26M-$6.20M
2025-03-31Reported$977.45M$970.23M$7.22M(m)83.11%$1.72M$870.10M(m)$108.97M$80.96M$63.27M
2024-12-31Reported-$155.63M-$162.39M$6.76M(m)-73.00%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$48.02M-$54.51M$6.49M(m)(m)$522.00K*-$76.99M*(m)$161.41M$73.46M$8.66M
2024-06-30Reported-$33.2M-$40.22M$7.02M(m)(m)-$7.38M*-$71.45M*(m)$132.17M$69.50M$13.45M
2024-03-31Reported$9.94M-$45.45M$55.4M(m)4.73%$9.59M$70.76M(m)$116.13M$73.27M$6.88M
2023-12-31Reported$86.53M$5.82M$80.71M(m)28.18%(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$56.11M-$118.16M$62.06M(m)(m)$6.36M*-$14.52M*(m)$164.21M$80.89M-$33.62M
2023-06-30Reported-$158.54M-$209.54M$51.01M(m)(m)$6.25M*-$14.12M*(m)$185.87M$88.45M-$38.60M
2023-03-31Reported-$74.79M-$117.62M$42.83M(m)-33.94%$10.27M-$29.49M(m)$195.12M$86.91M$3.97M
2022-12-31Reported-$161.48M-$200.34M$38.87M(m)-96.45%(m)(m)(m)(m)(m)(m)
2022-09-30Reported-$33.71M-$68.19M$34.48M(m)(m)$5.38M*-$38.05M*(m)$165.46M$80.12M-$17.89M
2022-06-30Reported-$63.18M-$92.36M$29.18M(m)(m)$8.70M*-$55.24M*(m)$157.26M$79.89M$3.39M
2022-03-31Reported-$60.21M-$86.52M$26.31M(m)-40.48%$9.31M-$97.40M(m)$140.08M$73.27M$4.83M
2021-12-31Reported-$65.92M-$84.73M$18.81M(m)-39.90%(m)(m)(m)(m)(m)(m)
2021-09-30Reported-$76.33M-$93.08M$16.75M(m)(m)$5.84M*-$51.19M*(m)$130.84M$69.25M-$36.00K
2021-06-30Reported-$83.51M-$98.49M$14.99M(m)(m)$7.97M*-$31.14M*(m)$125.48M$68.88M$488.00K
2021-03-31Reported-$84.56M-$98.15M$13.59M(m)-71.70%$5.67M-$100.16M(m)$134.51M$61.09M$451.00K
2020-12-31Reported-$83.97M-$96.37M$12.4M(m)-70.65%(m)(m)(m)(m)(m)(m)
2020-09-30Reported-$43.49M-$55.13M$11.64M(m)(m)$3.31M*$26.66M*(m)$93.00M$57.84M$22.29M
2020-06-30Reported-$177.06M-$187.27M$10.21M(m)(m)$2.16M*-$74.81M*(m)$176.53M$53.66M$84.00K
2020-03-31Reported-$83.76M-$92.99M$9.24M(m)-122.70%$6.02M-$81.55M(m)$90.11M$58.21M$222.00K
2019-12-31Reported-$83.01M-$72.78M-$10.23M(m)(m)(m)(m)(m)(m)(m)(m)
2019-09-30Reported-$45.31M-$60.48M$15.17M(m)(m)$4.25M*-$15.50M*$3.01M$63.08M$49.28M-$344.00K
2019-06-30Reported-$24.48M-$38.76M$14.28M(m)(m)$1.99M*-$30.52M*$3.21M$59.98M$49.22M$774.00K
2019-03-31Reported-$56M-$69.14M$13.14M(m)(m)$2.87M-$42.41M$2.38M$52.57M$40.54M$576.00K
2018-12-31Reported-$55.79M-$45.14M-$10.65M(m)(m)(m)(m)(m)(m)(m)(m)
2018-09-30Reported-$35.36M-$48.23M$12.87M(m)(m)$1.30M*$3.38M*$3.29M$54.37M$38.37M$355.00K
2018-06-30Reported$6.24M-$5.57M$11.81M(m)(m)$708.00K*$3.00K*$2.57M$32.61M$33.55M$389.00K
2018-03-31Reported-$5.29M-$16.74M$11.45M(m)(m)$479.00K-$15.88M$3.04M$31.36M$32.97M$221.00K
2017-12-31Reported$1.44M$5.45M-$4.02M(m)(m)(m)(m)(m)(m)(m)(m)
2017-09-30Reported-$10.88M-$30.89M$20.01M(m)(m)$479.00K*-$15.77M*$1.58M$30.02M$31.42M$191.00K
2017-06-30Reported-$11.66M-$12.5M$836,000.00(m)(m)$354.00K*$13.32M*$758.00K$30.84M$28.87M$150.00K
2017-03-31Reported-$25.74M-$26.36M$612,000.00(m)(m)$225.00K-$28.90M(m)$27.36M$25.50M$165.00K
2016-12-31Reported-$24.17M-$24.99M$823,000.00(m)(m)(m)(m)(m)(m)(m)(m)
2016-09-30Reported-$31.25M-$32.06M$813,000.00(m)(m)$265.00K*-$24.07M*(m)$31.40M$23.65M$184.00K
2016-06-30Reported-$35.75M-$36.56M$815,000.00(m)(m)$10.00K*(m)(m)$28.83M$23.37M-$93.00K
2016-03-31Reported-$37.59M-$38.44M$849,000.00(m)(m)$265.00K(m)(m)$31.40M$25.94M$114.00K
2015-12-31Reported-$47.38M-$48.2M$821,000.00(m)(m)(m)(m)(m)(m)(m)(m)
2015-09-30Reported-$41.47M-$42.23M$760,000.00(m)(m)$587.00K*(m)(m)$30.64M$21.37M$88.00K
2015-06-30Reported-$37.94M-$38.63M$685,000.00(m)(m)$294.00K*(m)(m)$28.19M$17.21M$145.00K
2015-03-31Reported-$37.44M-$38.07M$634,000.00(m)(m)$883.00K(m)(m)$27.94M(m)(m)
2014-12-31Reported-$31.69M-$32.23M$542,000.00(m)(m)(m)(m)(m)(m)(m)(m)
2014-09-30Reported-$27.06M-$27.6M$543,000.00(m)(m)$319.00K*(m)(m)$18.77M(m)(m)
2014-06-30Reported-$24.81M-$25.37M$562,000.00(m)(m)$651.00K*(m)(m)$18.31M(m)(m)
2014-03-31Reported-$13.62M-$14.21M$588,000.00(m)(m)$186.00K(m)(m)$15.89M(m)(m)
2013-12-31Reported-$17.51M-$18.09M$585,000.00(m)(m)(m)(m)(m)(m)(m)(m)
2013-09-30Reported-$3.69M-$4.28M$589,000.00(m)(m)$378.00K*(m)(m)$13.89M(m)(m)
2013-06-30Reported-$13.86M-$14.45M$597,000.00(m)(m)$75.00K*(m)(m)$14.71M(m)(m)
2013-03-31Reported-$7.95M-$8.58M$625,000.00(m)(m)$21.00K(m)(m)$11.26M(m)(m)
2012-12-31Reported-$5.38M-$6.03M$655,318.00(m)(m)(m)(m)(m)(m)(m)(m)
2012-09-30Reported-$6.39M-$7.06M$667,419.00(m)(m)$4.29K*(m)(m)$10.47M(m)(m)
2012-06-30Reported(m)-$7.50M(m)(m)(m)(m)(m)(m)$11.92M(m)(m)
2012-03-31Reported(m)-$6.22M(m)(m)(m)(m)(m)(m)(m)(m)(m)

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported$905.75M$866.94M$38.82M(m)52.34%$8.86M$711.20M(m)$455.25M$347.14M$13.97M
2024-12-31Reported-$226.91M-$302.57M$75.66M(m)-28.13%$6.50M-$107.69M(m)$534.48M$300.91M$176.00K
2023-12-31Reported-$202.91M-$439.5M$236.59M(m)-21.64%$28.44M-$158.42M(m)$666.56M$332.54M-$69.51M
2022-12-31Reported-$318.57M-$447.41M$128.84M(m)-45.59%$32.02M-$356.65M(m)$651.50M$326.00M-$28.47M
2021-12-31Reported-$310.31M-$374.44M$64.13M(m)-57.61%$28.21M-$251.33M(m)$540.68M$285.77M$5.56M
2021-09-30Rolling(m)-$386.09M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-06-30Rolling(m)-$348.15M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-03-31Rolling(m)-$436.93M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-12-31Reported-$388.28M-$431.77M$43.49M(m)-101.97%$17.84M-$194.07M(m)$477.64M$245.16M$35.23M
2020-12-31Rolling(m)-$431.77M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-09-30Rolling(m)-$408.18M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-06-30Rolling(m)-$413.52M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-03-31Rolling(m)-$265.01M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-12-31Reported-$208.98M-$241.16M$32.18M(m)-68.08%$13.76M-$98.64M$12.13M$257.45M$202.54M$11.65M
2019-12-31Rolling(m)-$241.16M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-09-30Rolling(m)-$213.51M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-06-30Rolling(m)-$201.27M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-03-31Rolling(m)-$168.08M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2018-12-31Reported-$89.6M-$115.69M$26.09M(m)-33.84%$7.10M-$27.64M$12.67M$171.98M$153.55M-$29.00K
2018-12-31Rolling(m)-$115.69M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2018-09-30Rolling(m)-$65.09M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2018-06-30Rolling(m)-$47.76M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2018-03-31Rolling(m)-$54.68M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2017-12-31Reported-$46.61M-$64.29M$17.68M(m)-23.98%$3.10M-$10.06M$4.58M$117.46M$121.27M$1.33M
2017-12-31Rolling(m)-$64.29M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2017-09-30Rolling(m)-$94.74M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2017-06-30Rolling(m)-$95.91M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2017-03-31Rolling(m)-$119.97M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2016-12-31Reported-$128.77M-$132.06M$3.29M(m)-155.70%$1.78M-$103.57M(m)$117.63M$97.13M$569.00K
2016-12-31Rolling(m)-$132.06M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2016-09-30Rolling(m)-$155.27M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2016-06-30Rolling(m)-$165.44M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2016-03-31Rolling(m)-$167.50M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2015-12-31Reported-$164.25M-$167.13M$2.88M(m)-446.76%$2.72M-$124.34M(m)$121.82M(m)$485.00K
2015-12-31Rolling(m)-$167.13M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2015-09-30Rolling(m)-$151.16M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2015-06-30Rolling(m)-$136.53M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2015-03-31Rolling(m)-$123.27M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2014-12-31Reported-$97.18M-$99.41M$2.24M(m)(m)$4.66M-$57.27M(m)$79.84M(m)-$4.69M
2014-12-31Rolling(m)-$99.41M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2014-09-30Rolling(m)-$85.28M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2014-06-30Rolling(m)-$61.95M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2014-03-31Rolling(m)-$51.03M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2013-12-31Reported-$43M-$45.4M$2.4M(m)(m)$846.00K(m)(m)$54.88M(m)(m)
2013-12-31Rolling(m)-$45.40M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2013-09-30Rolling(m)-$33.34M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2013-06-30Rolling(m)-$36.12M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2013-03-31Rolling(m)-$29.16M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2012-12-31Reported-$24.1M-$26.81M$2.7M(m)(m)$189.00K(m)(m)$46.14M(m)(m)
2012-12-31Rolling(m)-$26.81M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2011-12-31Reported$33.45M$30.58M$2.87M(m)(m)$165.12K(m)(m)$58.68M(m)-$2.31M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Dianthus Therapeutics, Inc. /DE/ (DNTH)United States$5.082B-27.79
Erasca, Inc. (ERAS)United States$5.073B-19.96
Gossamer Bio, Inc. (GOSS)United States$5.355B-0.65
Cogent Biosciences, Inc. (COGT)United States$5.450B-17.61
Veradermics, Inc (MANE)United States$4.839B
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
Edgewise Therapeutics, Inc. (EWTX)United States$4.470B-22.23
Viking Therapeutics, Inc. (VKTX)United States$4.287B-8.51